1.The Pattern of Care for Brain Metastasis from Breast Cancer over the Past 10 Years in Korea: A Multicenter Retrospective Study (KROG 16-12)
Jae Sik KIM ; Kyubo KIM ; Wonguen JUNG ; Kyung Hwan SHIN ; Seock-Ah IM ; Hee-Jun KIM ; Yong Bae KIM ; Jee Suk CHANG ; Jee Hyun KIM ; Doo Ho CHOI ; Yeon Hee PARK ; Dae Yong KIM ; Tae Hyun KIM ; Byung Ock CHOI ; Sea-Won LEE ; Suzy KIM ; Jeanny KWON ; Ki Mun KANG ; Woong-Ki CHUNG ; Kyung Su KIM ; Ji Ho NAM ; Won Sup YOON ; Jin Hee KIM ; Jihye CHA ; Yoon Kyeong OH ; In Ah KIM
Cancer Research and Treatment 2022;54(4):1121-1129
		                        		
		                        			 Purpose:
		                        			We aimed to investigate manifestations and patterns of care for patients with brain metastasis (BM) from breast cancer (BC) and compared their overall survival (OS) from 2005 through 2014 in Korea. 
		                        		
		                        			Materials and Methods:
		                        			We retrospectively reviewed 600 BC patients with BM diagnosed between 2005 and 2014. The median follow-up duration was 12.5 months. We categorized the patients into three groups according to the year when BM was initially diagnosed (group I [2005-2008], 98 patients; group II [2009-2011], 200 patients; and group III [2012-2014], 302 patients). 
		                        		
		                        			Results:
		                        			Over time, the median age at BM diagnosis increased by 2.2 years (group I, 49.0 years; group II, 48.3 years; and group III, 51.2 years; p=0.008). The percentage of patients with extracranial metastasis was 73.5%, 83.5%, and 86.4% for group I, II, and III, respectively (p=0.011). The time interval between BC and BM was prolonged in patients with stage III primary BC (median, 2.4 to 3 years; p=0.029). As an initial brain-directed treatment, whole-brain radiotherapy alone decreased from 80.0% in 2005 to 41.1% in 2014. Meanwhile, stereotactic radiosurgery or fractionated stereotactic radiotherapy alone increased from 13.3% to 34.7% during the same period (p=0.005). The median OS for group I, II, and III was 15.6, 17.9, and 15.0 months, respectively, with no statistical significance. 
		                        		
		                        			Conclusion
		                        			The manifestations of BM from BC and the pattern of care have changed from 2005 to 2014 in Korea. However, the OS has remained relatively unchanged over the 10 years. 
		                        		
		                        		
		                        		
		                        	
2.Assessment for Macular Thickness after Uncomplicated Phacoemulsification Using Optical Coherence Tomography
Byung-Jin KIM ; Ye Jin AHN ; Hye-Young OH ; Soon Il CHOI ; Young-Sik YOO ; Woong-Joo WHANG ; Yong-Soo BYUN ; Mee-yon LEE ; Choun-Ki JOO
Korean Journal of Ophthalmology 2022;36(4):296-305
		                        		
		                        			 Purpose:
		                        			Macular edema including cystoid macular edema is one of the main causes of unfavorable visual outcomes after cataract surgery. The macular thickness and the occurrence of macular edema after uncomplicated cataract surgery was evaluated using optical coherence tomography (OCT) in this study. 
		                        		
		                        			Methods:
		                        			Macular map images were taken by OCT before surgery and at 1 week, 1 month, and 2 months postsurgery. The subjects were classified into two groups (group 1, patients with no macular edema; group 2, patients with macular edema). Group 2 was defined as increase in central macular thickness (CMT) by 30% compared with that before surgery. The risk factors for macular edema were evaluated. Group 2 was divided into two subgroups: subclinical macular edema (group 2A) and cystoid macular edema (group 2B) and they were assessed in terms of the clinical course of best-corrected visual acuity and CMT. 
		                        		
		                        			Results:
		                        			A total of 376 patients were enrolled in this study, of which 36 (9.57%, group 2) showed macular edema measured by OCT after the surgery. Univariate analysis for group 1 and 2 revealed that intracameral injection of epinephrine during phacoemulsification was associated with the development of macular edema. In group 2, five patients (1.33%) developed cystoid macular edema. Statistically significant differences in the clinical course of CMT were observed at 2 months (201.2 ± 23.1, 250.0 ± 29.8, and 371.0 ± 160.3 in group 1, group 2A, and group 2B, respectively; p < 0.001) and 1 month postoperatively (198.5 ± 23.6, 237.8 ± 40.9, and 314.0 ± 104.5 in group 1, group 2A, and group 2B, respectively; p < 0.001). Group 2B required additional treatment and eventually achieved best-corrected visual acuity of >0.2 with CMT in the normal range. 
		                        		
		                        			Conclusions
		                        			The intracameral injection of epinephrine may cause macular edema after uncomplicated cataract surgery. Examination of CMT using OCT is recommended for the early detection of macular edema. 
		                        		
		                        		
		                        		
		                        	
3.The Clinical Features of Preschool Children With Speech and Language Disorder and the Role of Maternal Language
Hyeong Seop KIM ; Heesuk SHIN ; Chul Ho YOON ; Eun Shin LEE ; Min-Kyun OH ; Se-Woong CHUN ; Seung-Kyu LIM ; Hoi Sik MIN ; Hayoung BYUN
Annals of Rehabilitation Medicine 2021;45(1):16-23
		                        		
		                        			 Objective:
		                        			To retrospectively review the characteristics of preschool children with speech and language disorders to determine their clinical features and compares the average degrees of language delay based on hospital visit purposes, language developmental delay causes, and maternal language. 
		                        		
		                        			Methods:
		                        			One thousand one hundred two children (832 males, 270 females) with the chief complaint of language or speech problems who underwent language assessment for the first time were included. Their medical records, including demographic data, language environments, and family history of language problems and other developmental problems, were collected. Furthermore, the results of language and developmental assessments and hearing tests were collected. 
		                        		
		                        			Results:
		                        			Among the children enrolled in this study, 24% had parental problems and 9% were nurtured by their grandparents. The average degree of language delay did not differ regarding purposes of hospital visits. The average degree of language delay was greatest in children with autism spectrum disorders and least in children with mixed receptive–expressive language disorders. In children with mothers who do not speak Korean as their native language, social quotients in the social maturity scale were less than 70. 
		                        		
		                        			Conclusion
		                        			Language environment is an essential factor that may cause speech and language disorders. Moreover, maternal language seems to affect the social quotient of the social maturity scale. 
		                        		
		                        		
		                        		
		                        	
4.Erratum: Correction of Affiliations in the Article “Clinical Characteristics and Treatment Outcomes in Children, Adolescents, and Young-adults with Hodgkin's Lymphoma: a KPHOG Lymphoma Working-party, Multicenter, Retrospective Study”
Jae Min LEE ; Jung Yoon CHOI ; Kyung Taek HONG ; Hyoung Jin KANG ; Hee Young SHIN ; Hee Jo BAEK ; Hoon KOOK ; Seongkoo KIM ; Jae Wook LEE ; Nack-Gyun CHUNG ; Bin CHO ; Seok-Goo CHO ; Kyung Mi PARK ; Eu Jeen YANG ; Young Tak LIM ; Jin Kyung SUH ; Sung Han KANG ; Hyery KIM ; Kyung-Nam KOH ; Ho Joon IM ; Jong Jin SEO ; Hee Won CHO ; Hee Young JU ; Ji Won LEE ; Keon Hee YOO ; Ki Woong SUNG ; Hong Hoe KOO ; Kyung Duk PARK ; Jeong Ok HAH ; Min Kyoung KIM ; Jung Woo HAN ; Seung Min HAHN ; Chuhl Joo LYU ; Ye Jee SHIM ; Heung Sik KIM ; Young Rok DO ; Jae Won YOO ; Yeon Jung LIM ; In-Sang JEON ; Hee won CHUEH ; Sung Yong OH ; Hyoung Soo CHOI ; Jun Eun PARK ; Jun Ah LEE ; Hyeon Jin PARK ; Byung-Kiu PARK ; Soon Ki KIM ; Jae Young LIM ; Eun Sil PARK ; Sang Kyu PARK ; Eun Jin CHOI ; Young Bae CHOI ; Jong Hyung YOON ;
Journal of Korean Medical Science 2021;36(4):e37-
		                        		
		                        		
		                        		
		                        	
5.Correction: The Clinical Features of Preschool Children With Speech and Language Disorder and the Role of Maternal Language
Hyeong Seop KIM ; Heesuk SHIN ; Chul Ho YOON ; Eun Shin LEE ; Min-Kyun OH ; Se-Woong CHUN ; Seung-Kyu LIM ; Hoi Sik MIN ; Hayoung BYUN
Annals of Rehabilitation Medicine 2021;45(3):224-224
		                        		
		                        		
		                        		
		                        	
6.Correction: The Clinical Features of Preschool Children With Speech and Language Disorder and the Role of Maternal Language
Hyeong Seop KIM ; Heesuk SHIN ; Chul Ho YOON ; Eun Shin LEE ; Min-Kyun OH ; Se-Woong CHUN ; Seung-Kyu LIM ; Hoi Sik MIN ; Hayoung BYUN
Annals of Rehabilitation Medicine 2021;45(3):224-224
		                        		
		                        		
		                        		
		                        	
7.Descemet Membrane Endothelial Keratoplasty to Treat Graft Failure after Descemet Stripping Endothelial Keratoplasty
Si Eun OH ; Min Ji HA ; Woong Joo WHANG ; Yong-Soo BYUN ; Hyung Bin HWANG ; Kyung Sun NA ; Chang Rae RHO ; Hyun Soo LEE ; So-Hyang CHUNG ; Eun Chul KIM ; Yang Kyung CHO ; Hyun Seung KIM ; Man Soo KIM ; Ho Sik HWANG
Journal of the Korean Ophthalmological Society 2020;61(12):1532-1537
		                        		
		                        			Purpose:
		                        			We report a case of secondary Descemet membrane endothelial keratoplasty (DMEK) to treat graft failure after Descemet stripping endothelial keratoplasty (DSEK).Case summary: A 66-year-old female underwent DSEK of her right eye to treat pseudophakic bullous keratopathy that developed after cataract surgery and intraocular lens exchange. After 5 years, she complained of decreased vision; graft failure was observed. Secondary DMEK was performed; no additional air injection was needed. The corrected visual acuity was 0.2, 3 months after surgery, and the cornea became clear. 
		                        		
		                        			Conclusions
		                        			Visual recovery can be achieved by performing secondary DMEK after primary DSEK graft failure.
		                        		
		                        		
		                        		
		                        	
8.Descemet Membrane Endothelial Keratoplasty to Treat Graft Failure after Descemet Stripping Endothelial Keratoplasty
Si Eun OH ; Min Ji HA ; Woong Joo WHANG ; Yong-Soo BYUN ; Hyung Bin HWANG ; Kyung Sun NA ; Chang Rae RHO ; Hyun Soo LEE ; So-Hyang CHUNG ; Eun Chul KIM ; Yang Kyung CHO ; Hyun Seung KIM ; Man Soo KIM ; Ho Sik HWANG
Journal of the Korean Ophthalmological Society 2020;61(12):1532-1537
		                        		
		                        			Purpose:
		                        			We report a case of secondary Descemet membrane endothelial keratoplasty (DMEK) to treat graft failure after Descemet stripping endothelial keratoplasty (DSEK).Case summary: A 66-year-old female underwent DSEK of her right eye to treat pseudophakic bullous keratopathy that developed after cataract surgery and intraocular lens exchange. After 5 years, she complained of decreased vision; graft failure was observed. Secondary DMEK was performed; no additional air injection was needed. The corrected visual acuity was 0.2, 3 months after surgery, and the cornea became clear. 
		                        		
		                        			Conclusions
		                        			Visual recovery can be achieved by performing secondary DMEK after primary DSEK graft failure.
		                        		
		                        		
		                        		
		                        	
9.Clinical Characteristics and Treatment Outcomes in Children, Adolescents, and Young-adults with Hodgkin's Lymphoma:a KPHOG Lymphoma Working-party, Multicenter, Retrospective Study
Jae Min LEE ; Jung Yoon CHOI ; Kyung Taek HONG ; Hyoung Jin KANG ; Hee Young SHIN ; Hee Jo BAEK ; Seongkoo KIM ; Jae Wook LEE ; Nack-Gyun CHUNG ; Bin CHO ; Seok-Goo CHO ; Kyung Mi PARK ; Eu Jeen YANG ; Young Tak LIM ; Jin Kyung SUH ; Sung Han KANG ; Hyery KIM ; Kyung-Nam KOH ; Ho Joon IM ; Jong Jin SEO ; Hee Won CHO ; Hee Young JU ; Ji Won LEE ; Keon Hee YOO ; Ki Woong SUNG ; Hong Hoe KOO ; Kyung Duk PARK ; Jeong Ok HAH ; Min Kyoung KIM ; Jung Woo HAN ; Seung Min HAHN ; Chuhl Joo LYU ; Ye Jee SHIM ; Heung Sik KIM ; Young Rok DO ; Jae Won YOO ; Yeon Jung LIM ; In-Sang JEON ; Hee won CHUEH ; Sung Yong OH ; Hyoung Soo CHOI ; Jun Eun PARK ; Jun Ah LEE ; Hyeon Jin PARK ; Byung-Kiu PARK ; Soon Ki KIM ; Jae Young LIM ; Eun Sil PARK ; Sang Kyu PARK ; Eun Jin CHOI ; Young Bae CHOI ; Jong Hyung YOON ; Hoon KOOK ;
Journal of Korean Medical Science 2020;35(46):e393-
		                        		
		                        			 Background:
		                        			Hodgkin's lymphoma (HL) constitutes 10%–20% of all malignant lymphomas and has a high cure rate (5-year survival, around 90%). Recently, interest has increased concerning preventing secondary complications (secondary cancer, endocrine disorders) in long-term survivors. We aimed to study the epidemiologic features and therapeutic outcomes of HL in children, adolescents, and young adults in Korea. 
		                        		
		                        			Methods:
		                        			We performed a multicenter, retrospective study of 224 patients aged < 25 years diagnosed with HL at 22 participating institutes in Korea from January 2007 to August 2016. 
		                        		
		                        			Results:
		                        			A higher percentage of males was diagnosed at a younger age. Nodular sclerosis histopathological HL subtype was most common, followed by mixed cellularity subtype.Eighty-one (36.2%), 101 (45.1%), and 42 (18.8%) patients were classified into low, intermediate, and high-risk groups, respectively. Doxorubicin, bleomycin, vinblastine, dacarbazine was the most common protocol (n = 102, 45.5%). Event-free survival rate was 86.0% ± 2.4%, while five-year overall survival (OS) rate was 96.1% ± 1.4%: 98.7% ± 1.3%, 97.7% ± 1.6%, and 86.5% ± 5.6% in the low, intermediate, and high-risk groups, respectively (P = 0.021). Five-year OS was worse in patients with B-symptoms, stage IV disease, highrisk, splenic involvement, extra-nodal lymphoma, and elevated lactate dehydrogenase level.In multivariate analysis, B-symptoms and extra-nodal involvement were prognostic factors for poor OS. Late complications of endocrine disorders and secondary malignancy were observed in 17 and 6 patients, respectively. 
		                        		
		                        			Conclusion
		                        			This is the first study on the epidemiology and treatment outcomes of HL in children, adolescents, and young adults in Korea. Future prospective studies are indicated to develop therapies that minimize treatment toxicity while maximizing cure rates in children, adolescents, and young adults with HL. 
		                        		
		                        		
		                        		
		                        	
10.Causes of Failure during the Management Process from Identification of Brain-Dead Potential Organ Donors to Actual Donation in Korea: a 5-Year Data Analysis (2012–2016).
Mi im KIM ; Jaesook OH ; Won Hyun CHO ; Dong Sik KIM ; Cheol Woong JUNG ; Young Dong YOU ; Jun Gyo GWON ; Jae myeong LEE
Journal of Korean Medical Science 2018;33(50):e326-
		                        		
		                        			
		                        			BACKGROUND: This retrospective study analyzed the causes of failure in the management process from the identification of brain-dead potential organ donors to actual donation in Korea over the past 5 years. METHODS: Data of 8,120 potential brain deaths reported to the Korea Organ Donation Agency were used, including information received at the time of reporting, donation suitability evaluation performed by the coordinator after the report, and data obtained from interviews of hospital medical staff and the donor's family. RESULTS: From January 2012 to December 2016, the total number of brain-dead potential organ donors in Korea was 8,120, of which 2,348 (28.9%) underwent organ procurement surgery with designated recipients. While the number of transplant donors has increased over time, the ratio of transplant donors to medically suitable brain-dead donors has decreased. The common causes of donation failure included donation refusal (27.6%), non-brain death (15.5%), and incompatible donation (11.6%); 104 potential donors (7.8%) were unable to donate their organs because they were not pronounced brain dead. CONCLUSION: The rate of successful organ donation may be increased by analyzing the major causes of failure in the brain-dead organ donation management process and engaging in various efforts to prevent such failures.
		                        		
		                        		
		                        		
		                        			Brain Death
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Korea*
		                        			;
		                        		
		                        			Medical Staff, Hospital
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Statistics as Topic*
		                        			;
		                        		
		                        			Tissue and Organ Procurement
		                        			;
		                        		
		                        			Tissue Donors*
		                        			;
		                        		
		                        			Transplantation
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail